Tech Center 1600 • Art Units: 1645 1675
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18519225 | COMBINED USE OF UBENIMEX AND IMMUNE CHECKPOINT INHIBITOR | Non-Final OA | NIPPON KAYAKU KABUSHIKI KAISHA |
| 18400897 | TRANSKETOLASE EPITOPES, METHODS, AND DEVICES FOR IGG-BASED TUBERCULOSIS SERODIAGNOSIS | Non-Final OA | Wayne State University |
| 18397180 | VACCINATION AGAINST FUNGAL EPITOPES TO PREVENT INFLAMMATORY BOWEL DISEASES | Non-Final OA | THE UNIVERSITY OF UTAH |
| 18573574 | YEAST FOR THE TREATMENT OF INFLAMMATION | Non-Final OA | Milmed Unico AB |
| 18570867 | Bacteria and Herbal Extract Nutraceutical Blends for Lung Health Maintenance | Non-Final OA | RESBIOTIC NUTRITION, INC. |
| 18268844 | CONSTRUCTS COMPRISING SINGLE DOMAIN VHH ANTIBODIES AGAINST SARS COV-2 | Non-Final OA | Lumen Bioscience, Inc. |
| 18265405 | ANTI-EGFR CHIMERIC ANTIGEN RECEPTORS | Non-Final OA | Seattle Children's Hospital (dba Seattle Children's Research Institute) |
| 18002591 | CD-3 ANTIBODIES FOR THE TREATMENT OF CORONAVIRUS | Non-Final OA | Tiziana Life Sciences PLC |
| 18032491 | Methods of using passive immunity to decrease transmission of infectious diseases | Non-Final OA | CAMAS INCORPORATED |
| 18248238 | METHOD FOR TREATING OX40 RELATED DISEASE | Non-Final OA | Kyowa Kirin Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy